Oral administration of lactoferrin enhances the productions of IFN-γ and IL-10 in spleen cells cultured with concanavalin A or lipopolysaccharide

Biomedical Research

Volumn 20, Issue 1, 1999, Pages 27-33

  Nakajima, Mitsunari ^a,b   Iwamoto, Hiroshi ^a   Shirasawa, Takuji ^b   Miyauchi, Hirofumi ^a   Takatsu, Zenta ^a   Yamazaki, Natsuko ^a   Teraguchi, Susumu ^a   Hayasawa, Hirotoshi ^a  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTOGLOBULIN; CD11B ANTIGEN; CD4 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; LACTOFERRIN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; FEMALE; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE;

EID: 0032777103     PISSN: 03886107     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.20.27     Document Type: Article

References (26)

1. ARMITAGE R. J., FANSLOW W. C., STROCKBINE L., SATO T. A., CLIFFORS K. N., MACDUFF B. M., ANDERSON D. M., GIMPEL S. D., DAVIS SMITH T. and MALISZEWSKI C. R. (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80-82.
2. ARNOLD R. R., COLE M. F. and MCGHEE, J. R. (1977) A bactericidal effect for human lactoferrin. Science 197, 263-265.
3. BELLAMY W., TAKASE M., YAMAUCHI K., WAKABAYASHI H., KAWASE K. and TOMITA M. (1992) Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121, 130-136.
4. BOGDAN C., VODOVOTZ Y. and NATHAN C. (1991) Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555.
5. FIORENTINO D. F., BOND M. W. and MOSMANN T. R. (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095.
6. GAHR M., SPEER C. P., DAMERAU B. and SAWATZKI G. (1991) Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J. Leukocyte Biol. 49, 427-433.
7. GIACOMINI P., TECCE R., GAMBARI R., SACCHI A., FISHER P. B. and NATALI P. G. (1988) Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC-and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism. J. Immunol. 140, 3073-3081.
8. HORWITZ D. A., BAKKE A. C., ABO W. and NISHIYA K. (1984) Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J. Immunol. 132, 2370-2374.
9. JOHANSSON B. G. (1960) Isolation of an iron-containing red protein from human milk. Acta Chem. Scand. 14, 510-512.
10. LAW B. A. and REITER B. (1977) The isolation and bacteriostatic properties of lactoferrin from bovine milk whey. J. Dairy Res. 12, 439-464.
11. MASSON P. L. and HEREMANS J. F. (1966) Studies on lactoferrin, the iron-binding protein of secretions. Proc. Biol. Fluids 14, 115-124.
12. MAZURIER J., LEGRAND D., HU W. L., MONTREUIL J. and SPIK G. (1989) Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral bloob lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur. J. Biochem. 179, 481-487.
13. MILTENYI S., MULLER W., WEICHEL W. and RADBRUCH A. (1990) High gradient magnetic cell separation with MACS. Cytometry 11, 231-238.
14. NAKAJIMA M., SHINODA I., SAMEJIMA Y., MIYAUCHI H., FUKUWATARI Y. and HAYASAWA H. (1997) Lactoferrin as a suppressor of cell migration of gastrointestinal cell lines. J. Cell. Physiol. 170, 101-105.
15. NICHOLS B. L., MCKEE K. S., HENRY J. F. and PUTMAN, M. (1987) Human lactoferrin stimulates thymidine incorporation into DNA of rat crypt cells. Pediatr. Res. 21, 563-567.
16. NISHIYA K. and HORWITZ D. A. (1982) Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J. Immunol. 129, 2519-2523.
17. PACE J. L., RUSSELL S. W., TORRES B. A., JOHNSON H. M. and GRAY P. W. (1983) Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 130, 2011-2013.
18. POWRIE F. and COFFMAN R. L. (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 14, 270-274.
19. REATZ C. R. H. (1990) Biochemistry of endotoxins. Annu. Rev. Biochem. 59, 129-170.
20. SATO R., INANAMI O., TANAKA Y., TAKASE M. and NAITO Y. (1996) Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV) -positive and FIV-negative cats. Am. J. Vet. Res. 57, 1443-1446.
21. SECHLER J. M., MALECH H. L., WHITE C. J. and GALLIN J. I. (1988) Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc. Natl. Acad. Sci. USA 85, 4874-4878.
22. SEKINE K., UCHIDA Y., KUHARA T., IIGO M., BABA-TOMIYAMA H., MOORE M. A., MURAKOSHI M., SATOMI Y., NISHINO H., KAKIZOE T. and TSUDA H. (1997) Inhibition of initiation and early stage development of aberrant crypt foci and enhanced killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 121, 211-216.
23. SEKINE, K., WATANABE E., NAKAMURA J., TAKASUKA N., KIM D. J., ASAMOTO M., KRUTOVSKIKH V., BABA-TORIYAMA H., OTA T., MOORE M. A., MASUDA M., SUGIMOTO H., NISHINO H., KAKIZOE T. and TSUDA H. (1997) Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rat. Jpn. J. Cancer Res. 88, 523-526.
24. SHAU H., KIM A. and GOLUB H. (1992) Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukocyte Biol. 51, 343-349.
25. TOMITA M., BELLAMY W., TAKASE M., YAMAUCHI K., WAKABAYASHI H. and KAWASE K. (1991) Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 74, 4137-4142.
26. DE WAAL MALEFYT R., HAANEN J., SPITS H., RONCAROLO M. G., te VELDE A., FIGDOR C., JOHNSON K., KASTELEIN R., YSSEL H. and de VRIES J. E. (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924.